Categories: News

ICU Medical, Inc. Announces Time of Third Quarter 2021 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2021 earnings release and conference call.

The Company will release its third quarter 2021 results on Wednesday, November 3, 2021 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Wednesday, November 3, 2021. The call can be accessed at (877) 407-3982.The conference call will be simultaneously available by webcast, which can be accessed by going to the Company’s website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, and critical care applications. ICU Medical’s product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com

CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.

Staff

Recent Posts

FitSpresso Review: Why Fitspresso Coffee Loophole Is Better Than Other Weight Loss Supplement in 2025?

FitSpresso is the perfect choice for those seeking an effective solution to achieve healthy weight…

2 hours ago

Amid California Wildfires, eNavvi Mobilizes Unlimited Prescription Credits for Healthcare Providers

LOS ANGELES, Jan. 9, 2025 /PRNewswire/ -- In response to the widespread fires currently devastating Los…

11 hours ago

SynCardia Systems Receives Decision to Grant First Patent in China for the Emperor Next-Generation Total Artificial Heart

TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ -- SynCardia Systems, LLC ("SynCardia", or the "Company"), a…

11 hours ago

Danaher Announces Investment Partnership in Innovaccer Inc.

Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions.Investment aligns…

11 hours ago

TriNetX’s Founding CEO Announces Plans to Step Down

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's Board CAMBRIDGE, Mass.,…

11 hours ago